• 出版社/出版日：Mordor Intelligence / 2018年6月22日
|Single User（1名様用）||￥459,000 (USD4,250)||▷ お問い合わせ|
|Team User（7名様用）||￥486,000 (USD4,500)||▷ お問い合わせ|
|Corporate User||￥945,000 (USD8,750)||▷ お問い合わせ|
The global intrapartum monitoring devices market is expected to register a CAGR of about 7.0% during the forecast period of 2018-2023. Intrapartum monitoring refers to continual monitoring during labor. Along with the improvement in gynecological devices, the advancement in intrapartum monitoring devices play a vital role in maternal care. The market summed up by considering the monitors and screening electrodes used for intrapartum care.
Rising Preterm Births and Infant Mortality
The rise in infant mortality and preterm births globally are propelling the intrapartum monitoring devices market. The lack of access to appropriate maternal care facilities and disparities of income in different regions lead to difference in mortality rates across the world. The developing countries face greater challenge of infant mortality owing to presence of lower income groups, lack of infant care facilities, and unmet needs for obstetric care. According the statistics of WHO, the presence of effective postnatal, natal, and maternal care can facilitate survival of 3 quarters of the premature babies reducing the overall mortality rate.
Moreover, factors such as rising birth complications, and related increase in demand for infant and pregnancy care are expected to drive the market over the forecast period.
Issues Associated with Accessibility and Affordability
Majority of women in need of intrapartum care are unable to afford these facilities and avail the benefits of monitored labor. Hence, the need for development of affordable intrapartum monitoring devices is increasing. The healthcare in developing countries is focused on chronic disorders, such as cancer, cardiac disorders, and other infectious diseases. Thereby, reducing the focus on labor care or intrapartum care facilities. In addition, the intrapartum devices such as electrodes, transducers, and fetal monitors are cost-intensive. The electrodes are disposable and are not advised for reuse due to risks of infection. However, the higher costs associated with these electrodes for instance, disposable Fetal Scalp Electrodes (FSE) range from USD 7 to USD 12, and thus hamper their adoption.
Along with the affordability issues factors such as stringent regulatory guidelines for pregnancy care and monitoring are also obstructing the growth of the intrapartum monitoring devices market.
North America to Dominate the Market
North America is expected to dominate the intrapartum monitoring devices market. The dominance of this region can be attributed to the rising prevalence of gynecological diabetes miletus, increasing preterm births and growing cases of obesity.
Obesity being a major concern in the United States is the major contributor to the rising need for intrapartum monitoring in the country. The obese women are more susceptible to complications during labor. The women suffering from gynecological diabetes miletus are also prone to intrapartum issues and preterm deliveries. Hence, increasing prevalence of these diseases is expected to drive the market for intrapartum monitoring in North America.
Key Developments in the Market:
• May 2018 – Analogic Corporation announced the launch of its new bkSpecto Ultrasound platform for urology during the annual meeting of the American Urology Association.
• January 2018 – GE Healthcare entered into the strategic, collaboration with P&SHD and Ferozsons L.L. with Roche to jointly develop digital clinical decision support solutions for cancer and critical care patients.
Major Players – ANALOGIC CORPORATION, COOPER SURGICAL, GE HEALTHCARE, KONINKLIJKE PHILIPS N.V., MEDTRONIC PLC, MINDCHILD MEDICAL, OLYMPUS CORPORATION, AND STRYKER, amongst others.
Reasons to Purchase the Report
• The current and future outlook of the global intrapartum monitoring devices market in the developed and emerging markets.
• Analysis of various perspectives of the market with the help of Porter’s Five Forces Analysis.
• The segment that is expected to dominate the market.
• Regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3-month analyst support, along with the Market Estimate sheet (in Excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.レポート目次
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
5.3 Pipeline Analysis
5.4 Regulatory Framework
6. Market Dynamics
6.1 Market Drivers
6.1.1 Increasing Demand for Maternity Care Devices
6.1.2 Rising Preterm Birth and Infant Mortality
6.2 Market Restraints
6.2.1 Issues Associated with Accessibility and Affordability
6.2.2 Stringent Regulatory Guidelines
6.4 Key Challenges
7. Market Segmentation
7.1 By Product Type
220.127.116.11 Intrauterine Pressure Catheter (IUPC)
18.104.22.168 Transducer for Uterine Contractions
22.214.171.124 Fetal Scalp Electrodes
126.96.36.199 Transducer for Fetal Heart Rate
7.2 By Geography
7.2.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
7.2.4 Middle East & Africa
126.96.36.199 South Africa
188.8.131.52 Rest of Middle East & Africa
7.2.5 South America
184.108.40.206 Rest of South America
8. Competitive Landscape
8.1 Merger & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Analogic Corporation
9.2 Cooper Surgical
9.3 GE Healthcare
9.4 Koninklijke Philips N.V.
9.5 Medtronic PLC
9.6 MindChild Medical
9.7 Olympus Corporation
*List Not Exhaustive
10. Future of the Market